Funder: NOVARTIS FARMACEUTICA, S.A.
date_range Duration: from 17 March 2023 to 15 December 2023 (9 months) Finished
euro 26,000.00 EUR

Of National scope. With a Private character.

Call: (NOVARTIS FARMACEUTICA, S.A.)

Former participants (3)